D. E. Shaw & Co., Inc. Procept Bio Robotics Corp Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 187,860 shares of PRCT stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

187,860

Previous 25,054 649.82%

Holding current value

$11.9 Million

Previous $1.05 Million 784.19%

% of portfolio

0.01%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$40.38 - $50.75 $6.57 Million - $8.26 Million	162,806 Added 649.82%	187,860 $9.28 Million
Q4 2023 Feb 14, 2024	BUY	$24.89 - $43.41 $623,594 - $1.09 Million	25,054 New	25,054 $1.05 Million
Q1 2023 May 15, 2023	SELL	$26.64 - $39.74 $1.14 Million - $1.71 Million	-42,976 Reduced 45.01%	52,508 $1.49 Million
Q4 2022 Feb 14, 2023	SELL	$38.78 - $46.78 $376,553 - $454,233	-9,710 Reduced 9.23%	95,484 $3.97 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $2.78 Million - $4.56 Million	90,121 Added 597.9%	105,194 $4.36 Million

Q2 2022 Aug 15, 2022	BUY	$29.23 - $44.45 $440,583 - $669,994	15,073 New	15,073 $493,000
Q1 2022 May 16, 2022	SELL	$16.89 - $35.74 $1.19 Million - $2.51 Million	-70,214 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.6 - $46.29 $1.73 Million - $3.25 Million	70,214 New	70,214 $1.76 Million

Others Institutions Holding PRCT

# of Institutions

173

Shares Held

38.1M

Call Options Held

386K

Put Options Held

259K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $2.82B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account